Literature DB >> 340469

Absence of intercellular antigens in the deep layers of the epidermis in pemphigus foliaceus.

J C Bystryn, J Rodriguez.   

Abstract

12 patients with pemphigus foliaceus, a form of pemphigus with lesions that arise in the intercellular substance in the superficial layers of the epidermis, and 7 patients with pemphigus vulgaris, where lesions are in the deep layers, were studied by immunofluorescence. Circulating antibodies to intercellular antigens (IC antibodies) were found in 11 pemphigus foliaceus and 5 pemphigus vulgaris patients. On direct immunofluorescence of skin lesions 75% (9 of 12), pemphigus foliaceus patients had intercellular deposits of IgG localized solely or predominantly in the superficial epidermal layers, whereas this was not the case in any of the patients with pemphigus vulgaris. Over 70% of the pemphigus foliaceus patients with predominantly superficial IgG deposits lacked in their lesions normal intercellular antigens usually expressed in the deep layers of the epidermis. This was shown by the inability of IC antibodies in autologous or allogeneic sera to bind to intercellular antigens in the lower epidermis of patient's skin, even though the same sera could bind to intercellular antigens in all layers of normal allogeneic skin. Lack of normal intercellular antigens deep in the epidermis may result in circulating IC antibodies binding to the superficial layers, a site which corresponds to, and thus in some patients may account for, the anatomical location of lesions in pemphigus foliaceus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 340469      PMCID: PMC372544          DOI: 10.1172/JCI108944

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  AN ELECTRON MICROSCOPIC STUDY OF ACANTHOLYSIS AND DYSKERATOSIS IN PEMPHIGUS FOLIACEUS: WITH A SPECIAL NOTE ON PECULIAR INTRACYTOPLASMIC BODIES.

Authors:  G F WILGRAM; J B CAULFIELD; E B MADGIC
Journal:  J Invest Dermatol       Date:  1964-11       Impact factor: 8.551

2.  DEMONSTRATION OF SKIN ANTIBODIES IN SERA OF PEMPHIGUS VULGARIS PATIENTS BY INDIRECT IMMUNOFLUORESCENT STAINING.

Authors:  E H BEUTNER; R E JORDON
Journal:  Proc Soc Exp Biol Med       Date:  1964-11

3.  AUTOANTIBODIES IN PEMPHIGUS VULGARIS: RESPONSE TO AN INTERCELLULAR SUBSTANCE OF EPIDERMIS.

Authors:  E H BEUTNER; W F LEVER; E WITEBSKY; R JORDON; B CHERTOCK
Journal:  JAMA       Date:  1965-05-24       Impact factor: 56.272

4.  Clinical significance of autoantibodies in pemphigus.

Authors:  T P Chorzelski; J F Von Weiss; W F Lever
Journal:  Arch Dermatol       Date:  1966-05

5.  Indirect cutaneous immunofluorescence. I. Morphologic observations in bullous diseases, malignancies, and connective tissue diseases.

Authors:  T K Burnham; G Fine
Journal:  Arch Dermatol       Date:  1972-01

6.  Complement immunofluorescent staining in bullous pemphigoid.

Authors:  R E Jordon; W M Sams; E H Beutner
Journal:  J Lab Clin Med       Date:  1969-10

7.  [Anti-epidermal antibodies in bullous dermatoses. Clinical and experimental data].

Authors:  J Thivolet; A J Beyvin
Journal:  Bull Soc Fr Dermatol Syphiligr       Date:  1967

8.  An electron microscopic study on pemphigus vulgaris of the mouth and the skin with special reference to the intercellular cement.

Authors:  K Hashimoto; W F Lever
Journal:  J Invest Dermatol       Date:  1967-06       Impact factor: 8.551

9.  Destruction of epithelial cells in vivo by antiepithelial autoantibodies.

Authors:  T M Inderbitzin; P J Grob
Journal:  J Invest Dermatol       Date:  1967-12       Impact factor: 8.551

10.  Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum.

Authors:  J R Schiltz; B Michel
Journal:  J Invest Dermatol       Date:  1976-08       Impact factor: 8.551

View more
  12 in total

Review 1.  Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Authors:  J R Stanley
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

2.  Distinguishing the antigen specificities of pemphigus vulgaris and pemphigus foliaceus using the biotin-avidin immunofluorescence method.

Authors:  T Muramatsu; K Sakamoto; S Ikeda; H Ogawa
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

3.  Complement fixation by Brazilian Pemphigus foliaceus autoantibodies.

Authors:  S Kawana; L A Diaz; E A Rivitti; W D Geoghegan; R E Jordon
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

4.  Role of plasminogen activator in pemphigus vulgaris.

Authors:  J E Wilkinson; C A Smith; M M Suter; W Falchek; R M Lewis
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

5.  Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen.

Authors:  R W Eyre; J R Stanley
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

Review 6.  Immunologically mediated epidermal cell injury.

Authors:  R D Sontheimer; J N Gilliam
Journal:  Springer Semin Immunopathol       Date:  1981-06

7.  Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes.

Authors:  J R Stanley; M Yaar; P Hawley-Nelson; S I Katz
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

8.  Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies.

Authors:  J R Stanley; L Koulu; C Thivolet
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

9.  Avidin-biotin-peroxidase complex immunohistochemistry to detect immunoglobulin in formalin fixed skin biopsies in canine autoimmune skin disease.

Authors:  D M Haines; E M Cooke; E G Clark
Journal:  Can J Vet Res       Date:  1987-01       Impact factor: 1.310

10.  Subclass distribution of human IgG autoantibodies in pemphigus.

Authors:  C C Jones; R G Hamilton; R E Jordon
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.